Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancerSwati Dhar(University of Mississippi Medical Center), Anait S. Levenson(Long Island University)OncotargetMarch 1, 201610.18632/oncotarget.7841Cited by 63SaveCiteExport RISWatch citationsRelated PapersNuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans|Scientific Reports|2013|50The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer|Cancers|2024|6